Chronic ischemic syndrome management in 2024: are we ready for the (r)evolution?
Join our Satellite Symposium at ESC 2024 addressing the role of metabolic agents in ischemic disease and patient needs from the results of the PACT Angina survey, chaired by Mario Marzilli (Italy) and Rasha Al-Lamee (UK).
Objectives
- To highlight the evolving environment of chronic coronary syndrome management, supporting the need to move from "coronary syndrome" to "myocardial ischaemic syndrome".
- To translate new ESC chronic coronary syndrome guidelines into clinical practice.
- To discuss the evolution of angina management with a focus on the need of combined therapy.
- To present real insights from health care professional & patient surveys to share best practices in managing angina.
Agenda
- lntroduction
R. AL-LAMEE (UK) - Evolving environment of chronic coronary syndrome management in 2024
C. BERRY (UK) - Addressing ischemic disease with a metabolic agent
L. GOWDAK (BRAZIL) - Are we addressing patients’ needs? PACT Angina survey results
R. AGARWAL (INDIA) - Discussion
ALL - Conclusion
M. MARZILLI (ITALY)
The symposia are intended for healthcare professionals outside the UK. Servier products will be discussed.